About Watson Pharma Private Limited
Data last updated:
Watson Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Watson Laboratories Inc. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 21 October 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2005PTC156968. Its GSTIN is 27AAACW6074D1ZC (Maharashtra). The company holds 3 GST registrations, all of them active.
The company has an authorised share capital of ₹200 Cr and a paid-up capital of ₹161.98 Cr. It is led by directors including Nishank Bhargava and Hemant Kumar Manilal Mamania.
Its last annual general meeting (AGM) was held on 01 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹1,019.98 Cr, a decline of 7% compared to the previous year. For the same year it recorded a net profit of ₹119.66 Cr (net margin 11.7%) and EBITDA of ₹216.03 Cr (EBITDA margin 21.2%). Revenue has grown at a compounded annual rate (CAGR) of 11% over three years and 1% over five years.
The company has about 881 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Pfizer. As per MCA filings, the company has open charges of ₹25 Cr and satisfied charges of ₹8.6 Cr on record. Court records list 24 cases involving the company, including 9 filed by the company and 15 filed against it; 3 cases are pending. The company has 3 deals on record (2 funding rounds, 1 secondary share transfer), with disclosed funding of ₹235.13 Cr; the latest was in August 2023. Its 4 peer companies in the Pharma industry (API Manufacturers, Contract Research), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 1 larger and 3 smaller; the largest is Dalas Biotech Limited with revenue of ₹1,050.04 Cr. The company has 17 MSME Form 1 returns on record between 2018 and 2024, listing 1,083 overdue payments to 138 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website tevapharm.in.
Company details
Contact details
Watson Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its website is tevapharm.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address8th Floor Tower C Times Square Andheri Kurla Road Gamdevi Marol Andh, Eri East, Mumbai, Maharashtra, India – 400059
- IndustryPharma, API Manufacturers, Pharma Contract R&D
To see the full contact details of Watson Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Watson Pharma operates one associated brand: Pfizer. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical products for treating multiple diseases are provided. | pfizer.com |
Business activity
The main business activities of Watson Pharma are manufacturing and professional, scientific and technical. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and other professional, scientific and technical activities. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | |
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities |
To see the full business activity and turnover split of Watson Pharma Private Limited, buy the company report.
Financials of Watson Pharma Private Limited
FY 2025 filings availableWatson Pharma Private Limited reported revenue of ₹1,019.98 Cr (down 7% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 7% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 1%. EBITDA fell 13% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹216.03 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹119.66 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 21.2% | ||||
| Net Profit Margin | 11.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Watson Pharma Private Limited, buy the company report.
Board of directors of Watson Pharma Private Limited
Watson Pharma has 4 current directors and 26 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nishank Bhargava Also directs: Actavis Pharma Development Centre Private Limited, Tevapharm India Private Limited, Teva India Private Limited and 1 more | Director | 24 Feb 2022 | 4 Years 8 Months | Current |
| Hemant Kumar Manilal Mamania | Director | 03 Jan 2022 | 4 Years 10 Months | Current |
| Agnieszka Monika Lubkowska | Director | 26 Jun 2024 | 2 Years 4 Months | Current |
| Chandrasekhar Bhagwan Sinha | Director | 08 Aug 2025 | 1 Years 3 Months | Current |
Peer comparison
Watson Pharma Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (API Manufacturers, Contract Research), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Dalas Biotech Limited | ₹1,050.04 Cr (FY 2024) | 43.0% | Bhiwadi, Rajasthan, India | |||
| Watson Pharma Private Limitedthis company | ₹1,019.98 Cr (FY 2025) | ₹119.66 Cr | 11.7% | -7.0% | 881 | Mumbai, Maharashtra, India |
| Otsuka Chemical (India) Private Limited | ₹1,013.6 Cr (FY 2025) | -5.0% | New Delhi, Delhi, India | |||
| Chemspec Chemicals Private Limited | ₹974.7 Cr (FY 2025) | 0.0% | Navi Mumbai, Maharashtra, India | |||
| Lee Pharma Limited | ₹928.7 Cr (FY 2025) | 2.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Watson Pharma Private Limited, buy the company report.
Auditor
Watson Pharma Private Limited is audited by S R B C & CO LLP for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S R B C & CO LLP | FY 2024 | 324982E/E300003 |
Shareholding
The shareholding of Watson Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Watson Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 23 Jun 2009 | 10163588 | Hdfc Bank Limited | ₹25 Cr | Open | |
| 29 Nov 2005 | 90236482 | Standard Chartered Bank | ₹80 Lakh | Satisfied | |
| 23 Aug 2005 | 90236453 | Standard Chartered Bank | ₹80 Lakh | Satisfied | |
| 30 Oct 2002 | 90164293 | Bank of Baroda | ₹3.5 Cr | Satisfied | |
| 18 Jan 2002 | 80006101 | Corporation Bank | ₹3.5 Cr | Satisfied |
To see the full charge records of Watson Pharma Private Limited, buy the company report.
Total charge records: 5 View all charges
Deals & funding
Watson Pharma Private Limited has 3 deals on record (2 funding rounds, 1 secondary share transfer), with disclosed funding of ₹235.13 Cr; the latest was in August 2023.
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Aug 2023 | Secondary share transfer | Undisclosed | Seller: Watson Laboratories INC |
| Nov 2007 | Funding round | ₹216.16 Cr | Investors: Watson Laboratories INC |
| Nov 2007 | Funding round | ₹18.97 Cr | Investors: Watson Laboratories INC, Watson Laboratories INC & Merchant Vithaldas Kalpana, Watson Laboratories INC & Vaidya Shailesh |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Watson Pharma Private Limited has 24 court cases on record: 9 filed by Watson Pharma, 15 filed against it. 3 cases are pending and 21 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 13 | 12 | 0 |
| High courts | 10 | 3 | 3 |
| Supreme Court | 1 | 0 | 0 |
Cases on record (5 of 24)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Gurugram, Haryana | Court case (CS37) | Filed against the company by Ms Donaldson India Filter Systems Pvt Ltd | Disposed |
| Bombay High Court | Writ petition | Filed by the company against Union of India THR the Secretary and 4 Ors | Pending |
| High Court, MAHARASHTRA | Writ petition | Filed by the company against The Union of India Through the Secretary and 4 Ors. and 4 others | Pending |
| Bombay High Court | Writ petition | Filed by the company against The Union of India, Through Secretary, Ministry of Commerce and Industry and Ors | Pending |
| District court, Mumbai City Civil Court, Maharashtra | Court case (REVIEW PETITION) | Filed against the company by Bhavin Babu Patel - Applicant - Watson Pharama Pvt. Ltd. Org. Def. | Disposed |
To see the full case history of Watson Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Watson Pharma Private Limited has 17 MSME Form 1 returns on record between 2018 and 2024, listing 1,083 overdue payments to 138 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 138)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| B.Patel & Sons | |||
| Shantilal M Shah & Sons | |||
| an individual supplier | |||
| Cleanchem Laboratories LLP |
To see the full MSME payment records of Watson Pharma Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Watson Pharma Private Limited has a workforce of 881 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 881 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Watson Pharma Private Limited, buy the company report.
GST
Watson Pharma has 3 GST registrations: 3 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACW6074D1ZC | Maharashtra | Active | 01 Jul 2017 |
| 27AAACW6074D2ZB | Maharashtra | Active | 27 Mar 2025 |
| 30AAACW6074D1ZP | Goa | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Watson Pharma Private Limited, buy the company report.
Recent activity
Watson Pharma Private Limited has 30 board changes on record since 2006: 4 appointments and 26 cessations. The latest: Chandrasekhar Bhagwan Sinha ceased to be Additional Director on 31 Aug 2025.
31 earlier events are in the company report.
Frequently asked questions
Watson Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 21 October 2005 (21+ years old) and is registered under CIN U24230MH2005PTC156968.
Watson Pharma has 4 current directors:
- Nishank Bhargava - Director
- Hemant Kumar Manilal Mamania - Director
- Agnieszka Monika Lubkowska - Director
- Chandrasekhar Bhagwan Sinha - Director
The latest financial statements of Watson Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 01 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Watson Pharma is 27AAACW6074D1ZC, registered in Maharashtra. The company has 3 GST registrations in all, of which 3 are active. Other active GSTINs include 27AAACW6074D2ZB (Maharashtra), 30AAACW6074D1ZP (Goa).
The CIN (Corporate Identification Number) of Watson Pharma is U24230MH2005PTC156968. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Watson Pharma has 24 court cases on record: 9 filed by the company and 15 filed against it. 3 are pending. Most are in the district courts.
Watson Pharma was incorporated on 21 October 2005, making it 21+ years old. It is registered with the Registrar of Companies, Mumbai.
Watson Pharma has 3 deals on record (2 funding rounds, 1 secondary share transfer), with disclosed funding of ₹235.13 Cr; the latest was in August 2023.
The peers of Watson Pharma by revenue are Dalas Biotech Limited, Otsuka Chemical (India) Private Limited, Chemspec Chemicals Private Limited, Lee Pharma Limited, all in the Pharma industry (API Manufacturers, Contract Research), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Chandrasekhar Bhagwan Sinha ceased to be Additional Director on 31 Aug 2025. Chandrasekhar Bhagwan Sinha was appointed as Director on 08 Aug 2025. Agnieszka Monika Lubkowska ceased to be Additional Director on 28 Aug 2024. Watson Pharma has 30 board changes on record in total.
Watson Pharma has 17 MSME Form 1 returns on record between 2018 and 2024, listing 1,083 overdue payments to 138 micro and small suppliers. The latest return was filed on 29 Apr 2024.
Watson Pharma can be reached through the website tevapharm.in. Its registered office is in Mumbai, Maharashtra, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
